ANEMOCYTE - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79188650
Serial Number
79188650
Registration Number
5215720
Word Mark
ANEMOCYTE
Status
700 - Registered
Status Date
2017-06-06
Filing Date
2015-09-11
Registration Number
5215720
Registration Date
2017-06-06
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-03-21
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
SAUNDERS, ANDREA DAWN
Statements
Description of Mark
The mark consists of the wording "ANEMOCYTE" in standard characters.
Goods and Services
Pharmaceutical and veterinary preparations, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for use in human and veterinary medicine; chemical preparations for pharmaceutical or medical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, syringes, infusion bags, vials and pharmaceutical preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for medical and pharmaceutical use for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; chemical preparations for pharmaceutical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical and veterinary purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use, namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes; biological reagents for medical use; medicinal products based on cells and genes, namely, somatic cells, genetically modified cells, viral vectors, nucleic acids and engineered tissues; products for somatic cell therapy, namely, adult stem cells, t-cells, b-cells, nk cells, dendritic cells, monocytes, macrophages, adipocytes, keratinocytes, erythrocytes, platelets, products for gene therapy, namely, genetically modified cells, viral vectors, nucleic acids; tissue engineered products, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace or restore a lost or impaired tissue or function; products for regenerative medicine, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace, restore or promote the repair, replacement or regeneration of a lost or impaired tissue or function; products for personalized medicine made of autologous cells or proteins or nucleid acids derived from individual genomic sequences; preparations made up of cells for medical or clinical use; preparations made up of nucleic acids, namely, nucleic acid sequences and chemical reagents for medical purposes; preparations made up of tissues, namely, biological tissue cultures for medical purposes; vaccines; recombinant proteins supplements; therapeutic kits consisting of therapeutic antibodies, buffers, and reagents for use in disease treatment and therapy
Goods and Services
Surgical apparatus and instruments for medical, dental and veterinary use; medical devices for the introduction of pharmaceutical preparations in the human body, in particular syringes and catheters; medical equipment, namely, centrifuges or other separation devices for the isolation of cell sub-populations from tissues and biopsies; surgical apparatus and instruments for medical and veterinary purpose; electrical medical instruments for use in electroporation of cells and tissues for gene transfer purposes, both in vivo and ex-vivo; electronic medical instruments for use in imaging for diagnostic purposes or for monitoring of vital signs of patients
Goods and Services
Services of laboratory analysis and industrial research in the medical and pharmaceutical fields; research and development in the pharmaceutical and biotechnology fields; research and development in the field of micro-organisms and cells; research and development in biochemistry; scientific research and development in biology; research and development in the field of diagnostic preparations; services of medical laboratories; Providing medical and scientific research information and data on developments in the medical and veterinary fields; scientific and technological services, namely, scientific research in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; consultancy to ensure compliance with quality standards and the design and validation of manufacturing processes in the scientific field and medical technology fields
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-07-08
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2016-07-08
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-07-08
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Julie B. Seyler
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1301822
International Registration Date
2015-09-11
International Publication Date
2016-07-07
International Renewal Date
2025-09-11
Auto Protection Date
2018-01-07
International Status
001 - Request for extension of protection established
International Status Date
2016-07-07
Priority Claimed In
True
Priority Claimed Date
2015-07-29
First Refusal In
True
Trademark Events
Event DateEvent Description
2016-07-07SN ASSIGNED FOR SECT 66A APPL FROM IB
2016-07-08NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-07-08ASSIGNED TO EXAMINER
2016-07-11NON-FINAL ACTION WRITTEN
2016-07-12APPLICATION FILING RECEIPT MAILED
2016-07-12NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2016-07-13REFUSAL PROCESSED BY MPU
2016-07-13NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2016-07-29REFUSAL PROCESSED BY IB
2016-10-11TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2016-10-11ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2016-11-16TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-12-07ASSIGNED TO LIE
2016-12-22CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-12-22TEAS/EMAIL CORRESPONDENCE ENTERED
2017-01-08FINAL REFUSAL WRITTEN
2017-01-08FINAL REFUSAL E-MAILED
2017-01-08NOTIFICATION OF FINAL REFUSAL EMAILED
2017-02-01EXAMINERS AMENDMENT -WRITTEN
2017-02-01EXAMINERS AMENDMENT E-MAILED
2017-02-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-02-01EXAMINER'S AMENDMENT ENTERED
2017-02-01EXAMINERS AMENDMENT -WRITTEN
2017-02-01EXAMINERS AMENDMENT E-MAILED
2017-02-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-02-01EXAMINER'S AMENDMENT ENTERED
2017-02-01APPROVED FOR PUB - PRINCIPAL REGISTER
2017-02-14LAW OFFICE PUBLICATION REVIEW COMPLETED
2017-03-01NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-03-01NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2017-03-01NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-03-17NOTIFICATION PROCESSED BY IB
2017-03-21PUBLISHED FOR OPPOSITION
2017-03-21OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-06-06REGISTERED-PRINCIPAL REGISTER
2017-09-06FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2017-09-14FINAL DISPOSITION PROCESSED
2017-09-14FINAL DISPOSITION NOTICE SENT TO IB
2017-10-28FINAL DECISION TRANSACTION PROCESSED BY IB
2018-02-22CHANGE OF NAME/ADDRESS REC'D FROM IB
2021-04-09NEW REPRESENTATIVE AT IB RECEIVED